Výsledky vyhledávání - "Richard T. Doocey"

Daclizumab Therapy Improves Outcome in Steroid Refractory Acute Graft Versus Host Disease (aGVHD)

Autor: Michael J. Barnett, Stephen H. Nantel, Matthew J. Greenwood, Kevin W. Song, John D. Shepherd, Thomas J. Nevill, Richard T. Doocey, Dawn Warkentin, Janet Nitta, Donna L. Forrest, Clayton A. Smith, Julye C. Lavoie, Donna E. Hogge, Cynthia L. Toze, Heather J. Sutherland, Alan Le

Publikováno v: Blood. 104:5092-5092

Steroid refractory aGVHD following allogeneic stem cell transplant (SCT) is associated with a long-term event-free survival (EFS) of less than 20%. Daclizumab is a humanised monoclonal antibody specific for the Tac subunit of the Interleukin-2 (IL-2)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::256a523c54c5a5a17f9e77af4901e664
https://doi.org/10.1182/blood.v104.11.5092.5092

Zobrazit plný text záznamu

Acceptable Outcomes for Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation (AlloSCT) for Relapsed Aggressive Non-Hodgkin’s Lymphoma (NHL)

Autor: Michael J. Barnett, Stephen H. Nantel, Randy D. Gascoyne, Julye C. Lavoie, Donna L. Forrest, Richard T. Doocey, Cynthia L. Toze, Heather J. Sutherland, Nicholas Voss, Thomas J. Nevill, Clayton A. Smith, Joseph M. Connors, Donna E. Hogge, John D. Shepherd, Kevin W. Song

Publikováno v: Blood. 104:3325-3325

Background: AlloSCT for the treatment of aggressive histology NHL is appealing on the grounds of providing both a tumour free graft and a graft versus lymphoma mechanism for disease clearance. Currently only modest experience has been acquired concer

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1ef455f7c7d0b588c5c647b3188eca76
https://doi.org/10.1182/blood.v104.11.3325.3325

Zobrazit plný text záznamu

Risk Stratification in Acute Promyelocytic Leukemia Based on Elevated White Cell Count and Reduced Platelet Count Does Not Identify Subsequent Relapses: A Retrospective Review of 60 Patients

Autor: Clayton A. Smith, Richard T. Doocey, Julye C. Lavoie, John D. Shepherd, Cynthia L. Toze, Donna L. Forrest, Donna E. Hogge, Kevin W. Song, Thomas J. Nevill, Heather J. Sutherland, Michael J. Barnett, Stephen H. Nantel

Publikováno v: Blood. 104:4522-4522

Acute promyelocytic leukemia (APL) has become one of the more readily treatable subtypes of acute myeloid leukemia on the basis of its particular sensitivity to anthracyclines and the introduction of the differentiating agent all-trans retinoic acid

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b2f909442d1462600bf48112ef9aa5b2
https://doi.org/10.1182/blood.v104.11.4522.4522

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání